Mobilising capital to help Australian health innovation scale
Australian health and medtech innovation has enormous potential, but too often the pathway from early promise to global scale remains difficult to navigate. HESTA’s anchor investment in Synthesis Capital marks an important step in strengthening the capital pathways, specialist support and ecosystem conditions needed to help high-potential ventures grow. Synthesis Capital has been established as […]
Mobilising capital to help Australian health innovation scale Read More »










